(Q34486033)

2 August 2017

1 reference

title

Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment (English)

1 reference

2 August 2017

0 references

0 references

1 reference

10

1 reference

2 August 2017

14

1 reference

2 August 2017

Paolo Giacobini

8

0 references

Nicolas de Roux

Nicolas de Roux

4

0 references

Andrew A Dwyer

Andrew A Dwyer

7

0 references

Vincent Prevot

Vincent Prevot

13

0 references

Manuel Tena-Sempere

Manuel Tena-Sempere

15

0 references

Jean-Pierre Hardelin

9

Jean-Pierre Hardelin

1 reference

2 August 2017

12

Nelly Pitteloud

1 reference

2 August 2017

Jacques Young

17

1 reference

ORCID Public Data File 2021

Richard Quinton

16

Richard Quinton

1 reference

2 August 2017

2

Pierre-Marc Bouloux

1 reference

2 August 2017

3

Mehul T Dattani

1 reference

2 August 2017

6

Leo Dunkel

1 reference

2 August 2017

Ulrich Boehm

1

1 reference

2 August 2017

Catherine Dodé

5

1 reference

2 August 2017

Mohamad Maghnie

11

1 reference

2 August 2017

publication date

21 July 2015

1 reference

Nature Reviews Endocrinology

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

547-564

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

2 August 2017

copyright license

start time

21 July 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversal of idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Effects of kisspeptin on hormone secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Neural crest and ectodermal cells intermix in the nasal placode to give rise to GnRH-1 neurons, sensory neurons, and olfactory ensheathing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Developmental regulation of gonadotropin-releasing hormone neurons by fibroblast growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Functionally compromised CHD7 alleles in patients with isolated GnRH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in FEZF1 cause Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Inactivating KISS1 mutation and hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The GPR54 gene as a regulator of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kisspeptins and reproduction: physiological roles and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Murine arcuate nucleus kisspeptin neurons communicate with GnRH neurons in utero.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Oestrogen, kisspeptin, GPR54 and the pre-ovulatory luteinising hormone surge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Sexual differentiation of Kiss1 gene expression in the brain of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Timing and completion of puberty in female mice depend on estrogen receptor alpha-signaling in kisspeptin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Neuroendocrine control by kisspeptins: role in metabolic regulation of fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Disparate changes in kisspeptin and neurokinin B expression in the arcuate nucleus after sex steroid manipulation reveal differential regulation of the two KNDy peptides in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Haploinsufficiency of Dmxl2, encoding a synaptic protein, causes infertility associated with a loss of GnRH neurons in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Leptin indirectly regulates gonadotropin-releasing hormone neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Leptin-dependent neuronal NO signaling in the preoptic hypothalamus facilitates reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The neural basis of puberty and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Human puberty - simultaneous augmented secretion of luteinizing hormone and testosterone during sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Developmental changes in 24-hour profiles of luteinizing hormone and follicle-stimulating hormone from prepuberty to midstages of puberty in boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The prepubertal testis: biomarkers and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Serum Inhibin A and Inhibin B in Healthy Prepubertal, Pubertal, and Adolescent Girls and Adult Women: Relation to Age, Stage of Puberty, Menstrual Cycle, Follicle-Stimulating Hormone, Luteinizing Hormone, and Estradiol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Onset of breast development in a longitudinal cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Recent decline in age at breast development: the Copenhagen Puberty Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Recent changes in pubertal timing in healthy Danish boys: associations with body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Micropenis: etiology, diagnosis and treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Growth and development of male external genitalia: a cross-sectional study of 6200 males aged 0 to 19 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Pubertal development in Danish children: comparison of recent European and US data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Clinical practice. Delayed puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Stage line diagram: an age-conditional reference diagram for tracking development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Expanding the phenotype and genotype of female GnRH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Approach to the Male Patient with Congenital Hypogonadotropic Hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Evaluation of 451 Danish boys with delayed puberty: diagnostic use of a new puberty nomogram and effects of oral testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Childhood growth of females with Kallmann syndrome and FGFR1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Impaired emotional state, quality of life and cognitive functions in young hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kallmann's syndrome: mirror movements associated with bilateral corticospinal tract hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Extracellular matrix protein anosmin promotes neural crest formation and regulates FGF, BMP, and WNT activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/Kiss1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Genetic counseling for isolated GnRH deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Variations in pattern of pubertal changes in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Variations in the Pattern of Pubertal Changes in Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Congenital hypogonadotropic hypogonadism during childhood: presentation and genetic analyses in 46 boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B, and testosterone during pubertal transition in healthy boys: a longitudinal pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Exogenous kisspeptin administration as a probe of GnRH neuronal function in patients with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Deletions of the steroid sulphatase gene in "classical" X-linked ichthyosis and in X-linked ichthyosis associated with Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kallmann syndrome in a patient with congenital spherocytosis and an interstitial 8p11.2 deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Deletions and translocations involving the distal short arm of the human X chromosome: review and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Custom oligonucleotide array-based CGH: a reliable diagnostic tool for detection of exonic copy-number changes in multiple targeted genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Clinical genetics of Kallmann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Fertility potential in men with a history of congenital undescended testes: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Nordic consensus on treatment of undescended testes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Effectiveness of hormonal and surgical therapies for cryptorchidism: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Ideal timing of orchiopexy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Early postnatal treatment of hypogonadotropic hypogonadism with recombinant human FSH and LH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Transition in endocrinology: induction of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Delayed puberty, eroticism, and sense of smell: A psychological study of hypogonadotropinism, osmatic and anosmatic (Kallmann's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

What is the optimal therapy for young males with hypogonadotropic hypogonadism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Kallmann's syndrome: is it always for life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversal of isolated hypogonadotropic hypogonadism: long-term integrity of hypothalamo-pituitary-testicular axis in two men is dependent on intermittent androgen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Gonadotropin Therapy in Men With Isolated Hypogonadotropic Hypogonadism: The Response to Human Chorionic Gonadotropin Is Predicted by Initial Testicular Size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Gonadotrophin replacement for induction of fertility in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Is intracytoplasmic sperm injection essential for the treatment of hypogonadotrophic hypogonadism? A comparison between idiopathic and secondary hypogonadotrophic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Approach to male infertility and induction of spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Fertility treatments and multiple births in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Approach to the patient with hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Ovulation induction: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Osteoprotection by semaphorin 3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Transition from pediatric to adult healthcare: assessment of specific needs of patients with chronic endocrine conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Transition of care for adolescents with disorders of sex development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Loss-of-Function Mutations in the Genes Encoding Prokineticin-2 or Prokineticin Receptor-2 Cause Autosomal Recessive Kallmann Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Increased Activity of the Hypothalamic-Pituitary-Testicular Axis in Infancy Results in Increased Androgen Action in Premature Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Patterns of pulsatile luteinizing hormone secretion before and during the onset of puberty in boys: a study using an immunoradiometric assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Insulin-Like Factor 3 and the HPG Axis in the Male.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Diagnosis of Kallmann's syndrome in early infancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Clues to an early diagnosis of Kallmann syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Acquired cryptorchidism is frequent in infancy and childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

PSYCHOLOGICAL STUDIES OF ADULT MALE PATIENTS WITH SEXUAL INFANTILISM BEFORE AND AFTER ANDROGEN THERAPY

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Prevalence of olfactory and other developmental anomalies in patients with central hypogonadotropic hypogonadism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Inhibin B plus LH vs GnRH agonist test for distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism in boys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Unilateral renal aplasia in X-linked Kallmann's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Renal dysgenesis and KAL1 gene defects in patients with sporadic Kallmann syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Genotype-phenotype correlation--promiscuity in the era of next-generation sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Pubertal induction in adult males with isolated hypogonadotropic hypogonadism using long-acting intramuscular testosterone undecanoate 1-g depot (Nebido)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Pulsatile GnRH Is Superior to hCG in Therapeutic Efficacy in Adolescent Boys With Hypogonadotropic Hypogonadodism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Induction of spermatogenesis in isolated hypogonadotrophic hypogonadism with gonadotrophins and early intervention with intracytoplasmic sperm injection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Gonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Quality assessment of induced spermatogenesis in hypogonadotrophic hypogonadic men treated with gonadotrophins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Physiological estrogen replacement therapy for puberty induction in girls: a clinical observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Anti-mullerian hormone deficiency in girls with congenital multiple pituitary hormone deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Management of anovulatory infertility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Osteoporosis in men with idiopathic hypogonadotropic hypogonadism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.112

Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients

31 March 2020

1 reference

12 December 2020

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

1 reference

12 December 2020

Plasma inhibin B and antimüllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay

1 reference

12 December 2020

Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women

1 reference

12 December 2020

Antimüllerian hormone in patients with hypogonadotropic hypogonadism

1 reference

12 December 2020

Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels.

1 reference

12 December 2020

Paternity after unilateral cryptorchidism: a controlled study

1 reference

12 December 2020

From paediatric to adult endocrinology care: the challenge of the transition period

1 reference

12 December 2020

Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels

1 reference

12 December 2020

Gonadotropin treatment of hypogonadotropic hypogonadal adolescents

1 reference

12 December 2020

Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations

1 reference

12 December 2020

The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human

1 reference

12 December 2020

Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome

1 reference

12 December 2020

Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group

1 reference

12 December 2020

Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations

1 reference

12 December 2020

Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory.

1 reference

12 December 2020

GnRH, anosmia and hypogonadotropic hypogonadism--where are we?

1 reference

12 December 2020

Craniofacial morphology in patients with Kallmann's syndrome with and without cleft lip and palate

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2015.112

1 reference

Dimensions Publication ID

2 August 2017

1032850883

0 references

1 reference